期刊文献+

肺表面活性物质与机械通气联合治疗肺透明膜病的疗效评价

Combination of pulmonary surfactant and mechanical ventilation to treat new-born infants hyaline membrane disease.
下载PDF
导出
摘要 目的 评价基层医院应用肺表面活性物质(PS)与机械通气联合治疗新生儿肺透明膜病(HMD)的疗效.方法 治疗组在上呼吸机及常规治疗12 h内给于PS,将传统方法改为快速注入间歇给药法;首剂给药量:150~200 mg/kg,重复给药量100 mg/kg.主要疗效评价指标:用PS后不同时期的氧合指数(OI)和动脉/肺泡氧分压(a/A PO2)变化及临床症状改善情况;次要疗效评价指标:机械通气时间、并发症发生率、存活率、住院天数.结果 治疗组临床症状缓解快,用PS后1 h、6 h、12 h、24 h,OI降低而a/A PO2增高,差异有显著性(P<0.01);上机时间缩短,呼吸机各项指标均在短时间内下调,住院时间缩短(P<0.01),无一例发生并发症.结论 PS与机械通气联合治疗HMD能快速、有效改善患儿肺功能,降低呼吸机治疗条件,上机时间、住院时间缩短, 疗效好,操作容易;降低机械通气并发症的发生率,值得在基层医院推广. Objective To evaluate the effectiveness of combination of pulmonary surfaetant and mechanical ventilation to treat new - born infants hyaline membrane disease treating newborn infant hyaline membrane disease (HMD)in subordinate hospitals. Methods Once the newborn infants were diagnosed as HMD,the group of newborn infants suffered from HMD were given PS two times within 12 hours being supported by ventilator. We alternated the routine method of PS given one intermission method within a short time ( the doses given were 150 - 200mg/kg and 100mg/kg rcspectively). The primary evaluated parameters: the Oxygenation index(OI) at different time after giving PS, Alveolar/Arterial ratio of PCO2 ( a/A PO2 ) ,getting improved in clinical conditions;The secondary evaluated parameters: Duration of supported by Ventilator, rate of complications, survival rate and duration of hospitalization. Results The clinical condition of treating group got improved soon after giving the PS 1 h, 6 h, 12 h, 24 h with decreasing of OI and increasing of a/A PO2. All were with significant statistic difference( P 〈0,001 ). Shorten duration for being supported by ventilator and relevant parameters could be down - regulated in a short time and an average time of hospitalization without complications in any case, P 〈 0.01. Conclusion mechanical ventilation combined with PS can improve lung function of newborn infants with HMD quickly, can shorten the duration of using ventilator and hospitalization. It is effective and easy to be operated. It is benefit for reducing complications. So it is worthy to be widely promoted at subordinate hospitals.
出处 《临床和实验医学杂志》 2006年第3期201-203,共3页 Journal of Clinical and Experimental Medicine
关键词 肺表面活性物质 机械通气 肺透明膜病 Pulmonary surfactant Mechanical ventilation Pulmonary hyaline membrane disease
  • 相关文献

参考文献5

二级参考文献10

  • 1Rodriguez RJ, Martin RJ. Exogenous surfactant therapy in newborns.Respir Care Clin N Am, 1999, 5: 595-616.
  • 2Sinn JK, Ward MC, Henderson - Smart DJ. Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health, 2002, 38:597-600.
  • 3Kelly E, Bryan H, Possmayer F. et al. Compliance of the respiratory system in newborn infants pre - and post surfactant replacement therapy.PadiatrPumonol, 1993, 15: 225-230.
  • 4Baraldi E, pettenazzo A, Filippone M. et al. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome. Pediatr Pulmonol, 1993, 15: 157- 162.
  • 5Enhorning G , Duffy LC, Welliver R . Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med,1995, 151: 554- 556.
  • 6金汉珍,实用新生儿学(第2版),1997年,350页
  • 7吴瑞萍,诸福棠实用儿科学(第6版),1996年,449页
  • 8宋国维,新生儿科杂志,1995年,1卷,57页
  • 9李军.肺表面活性物质替代疗法进展[J].国外医学(麻醉学与复苏分册),1997,18(6):357-360. 被引量:22
  • 10陆铸今,张灵恩.呼吸力学监测在儿科监护室中的应用[J].中国实用儿科杂志,2001,16(7):389-391. 被引量:1

共引文献195

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部